Events

All members have the option of attending our various HTC-centric events which include:

  • Spring and Fall Member Meetings: Bring HTC staff together to connect, share best practices, and learn about key issues impacting HTCs.
  • Continuing Education (CE) Meetings: Bring nurses, pharmacists, physical therapists, and social workers together for discipline-specific continuing education, peer learning, and networking in support of the bleeding disorders community.
  • New HTC Staff Meeting: Brings staff new to their HTC or transitioning into a more operational role together to build knowledge, make connections, and better understand 340B and HTC operations.
  • Medical Providers & Business Administrators (MPBA) Meeting: HTC leaders come together to connect, collaborate, and plan for the future.
  • Member Webinars: Educate our members on HTC operations and organizational management, payer relations, regulations and legal updates, advocacy, and manufacturer updates.


Relevant non-member meetings and events within the bleeding disorder community are also listed here.

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Takeda on FVIII Portfolio

Date: Thursday, March 20th, 2025 Time: 2:00pm - 3:00pm ET       TITLE: Takeda FVIII Portfolio OBJECTIVE: Please join Takeda leadership to review Takeda FVIII Products & Resources Available. INTENDED AUDIENCE: All HTC staff SPEAKER: Anthea Cherednichenko, VP US Hematology Franchise Head Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea Read the full article...

🟥 Member Webinar : Hemophilia Alliance Hosts – A webinar from Novo Nordisk on Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors

Date: Thursday, April 3rd, 2025 Time: 2:00pm - 3:00pm ET         WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors OBJECTIVE: To provide a prescribing information overview of the recently FDA approved medication, Alhemo (concizumab-mtci), for patients living with hemophilia A or B with Read the full article...